PMC:7589163 / 53290-53624 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T206","span":{"begin":139,"end":145},"obj":"Disease"}],"attributes":[{"id":"A206","pred":"mondo_id","subj":"T206","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"}],"text":"A randomized controlled, trial which included 736 pregnant women and a total of 695 children, showed that the risk of persistent wheeze or asthma was reduced by approximately 7% in the first 5 years of life among children of women who received daily supplementation with omega−3 PUFA (EPA/DHA) during the third trimester of pregnancy."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T527","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T528","span":{"begin":69,"end":70},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"A randomized controlled, trial which included 736 pregnant women and a total of 695 children, showed that the risk of persistent wheeze or asthma was reduced by approximately 7% in the first 5 years of life among children of women who received daily supplementation with omega−3 PUFA (EPA/DHA) during the third trimester of pregnancy."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T81148","span":{"begin":279,"end":283},"obj":"Chemical"},{"id":"T36825","span":{"begin":285,"end":288},"obj":"Chemical"},{"id":"T16119","span":{"begin":289,"end":292},"obj":"Chemical"}],"attributes":[{"id":"A43343","pred":"chebi_id","subj":"T81148","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"},{"id":"A31060","pred":"chebi_id","subj":"T81148","obj":"http://purl.obolibrary.org/obo/CHEBI_76567"},{"id":"A97748","pred":"chebi_id","subj":"T36825","obj":"http://purl.obolibrary.org/obo/CHEBI_28364"},{"id":"A37565","pred":"chebi_id","subj":"T16119","obj":"http://purl.obolibrary.org/obo/CHEBI_16016"},{"id":"A5647","pred":"chebi_id","subj":"T16119","obj":"http://purl.obolibrary.org/obo/CHEBI_28125"},{"id":"A2894","pred":"chebi_id","subj":"T16119","obj":"http://purl.obolibrary.org/obo/CHEBI_28689"},{"id":"A97211","pred":"chebi_id","subj":"T16119","obj":"http://purl.obolibrary.org/obo/CHEBI_36005"}],"text":"A randomized controlled, trial which included 736 pregnant women and a total of 695 children, showed that the risk of persistent wheeze or asthma was reduced by approximately 7% in the first 5 years of life among children of women who received daily supplementation with omega−3 PUFA (EPA/DHA) during the third trimester of pregnancy."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T101","span":{"begin":139,"end":145},"obj":"Phenotype"}],"attributes":[{"id":"A101","pred":"hp_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/HP_0002099"}],"text":"A randomized controlled, trial which included 736 pregnant women and a total of 695 children, showed that the risk of persistent wheeze or asthma was reduced by approximately 7% in the first 5 years of life among children of women who received daily supplementation with omega−3 PUFA (EPA/DHA) during the third trimester of pregnancy."}

{"project":"LitCovid-sentences","denotations":[{"id":"T325","span":{"begin":0,"end":334},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A randomized controlled, trial which included 736 pregnant women and a total of 695 children, showed that the risk of persistent wheeze or asthma was reduced by approximately 7% in the first 5 years of life among children of women who received daily supplementation with omega−3 PUFA (EPA/DHA) during the third trimester of pregnancy."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1350","span":{"begin":59,"end":64},"obj":"Species"},{"id":"1351","span":{"begin":84,"end":92},"obj":"Species"},{"id":"1352","span":{"begin":213,"end":221},"obj":"Species"},{"id":"1353","span":{"begin":225,"end":230},"obj":"Species"},{"id":"1362","span":{"begin":271,"end":283},"obj":"Chemical"},{"id":"1363","span":{"begin":289,"end":292},"obj":"Chemical"},{"id":"1368","span":{"begin":139,"end":145},"obj":"Disease"}],"attributes":[{"id":"A1350","pred":"tao:has_database_id","subj":"1350","obj":"Tax:9606"},{"id":"A1351","pred":"tao:has_database_id","subj":"1351","obj":"Tax:9606"},{"id":"A1352","pred":"tao:has_database_id","subj":"1352","obj":"Tax:9606"},{"id":"A1353","pred":"tao:has_database_id","subj":"1353","obj":"Tax:9606"},{"id":"A1363","pred":"tao:has_database_id","subj":"1363","obj":"MESH:C027493"},{"id":"A1368","pred":"tao:has_database_id","subj":"1368","obj":"MESH:D001249"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A randomized controlled, trial which included 736 pregnant women and a total of 695 children, showed that the risk of persistent wheeze or asthma was reduced by approximately 7% in the first 5 years of life among children of women who received daily supplementation with omega−3 PUFA (EPA/DHA) during the third trimester of pregnancy."}